Home  /  Resource Library  /  Clinical outcomes and spatial transcriptomic profiles of CD19/20 CAR-T therapy in relapsed or refractory B-cell non-Hodgkins lymphoma

Clinical outcomes and spatial transcriptomic profiles of CD19/20 CAR-T therapy in relapsed or refractory B-cell non-Hodgkins lymphoma

Results of a study investigating dual CAR-T for treatment of relapsed DLBCL.